Profil
Ross Bundy is the founder of CRISPRQC, Inc. He is currently working as the Chief Entrepreneur at Cardea Bio, Inc.
Postes actifs de Ross Helgren Bundy
Sociétés | Poste | Début |
---|---|---|
Cardea Bio, Inc.
Cardea Bio, Inc. BiotechnologyHealth Technology Cardea Bio, Inc. develops bioelectronics for use in research and diagnostics. Its products include AGILE 100 and pipeline. The company was founded by Ross Bundy, Kiana Aran, and Brett Goldsmith in 2013 and is headquartered in San Diego, CA. | Directeur/Membre du Conseil | - |
CRISPRQC, Inc.
CRISPRQC, Inc. BiotechnologyHealth Technology CRISPRQC, Inc. provides a comprehensive crispr analytics platform that enables scientists and researchers to optimize gene editing outcomes and ensure the highest levels of quality control. The company is based in San Diego, CA. The platform is built on the company's proprietary crispr-chip technology, which allows for direct, real-time measurement of crispr activity. The company strives to empower its customers with the insights needed to push forward the life-saving cures and sustainable agricultural advances fueled by crispr editing. CRISPRQC was founded by Ross Bundy and Kiana Aran, with Ross Bundy serving as the CEO since incorporation. | Directeur Général | - |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Entreprise privées | 2 |
---|---|
Cardea Bio, Inc.
Cardea Bio, Inc. BiotechnologyHealth Technology Cardea Bio, Inc. develops bioelectronics for use in research and diagnostics. Its products include AGILE 100 and pipeline. The company was founded by Ross Bundy, Kiana Aran, and Brett Goldsmith in 2013 and is headquartered in San Diego, CA. | Health Technology |
CRISPRQC, Inc.
CRISPRQC, Inc. BiotechnologyHealth Technology CRISPRQC, Inc. provides a comprehensive crispr analytics platform that enables scientists and researchers to optimize gene editing outcomes and ensure the highest levels of quality control. The company is based in San Diego, CA. The platform is built on the company's proprietary crispr-chip technology, which allows for direct, real-time measurement of crispr activity. The company strives to empower its customers with the insights needed to push forward the life-saving cures and sustainable agricultural advances fueled by crispr editing. CRISPRQC was founded by Ross Bundy and Kiana Aran, with Ross Bundy serving as the CEO since incorporation. | Health Technology |